Tech Company Financing Transactions
Eclipsebio Funding Round
Eclipsebio, based in San Diego, secured $14 million from Alexandria Venture Investments, iGlobe Partners and Phoenix Venture Partners.
Transaction Overview
Company Name
Announced On
3/22/2022
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Investors
Alexandria Venture Investments (Lead Investor) (Hallie Kuhn)
iGlobe Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its suite of RNA genomics technologies and products.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
5770 Oberlin Dr.
San Diego, CA 92121
United States
San Diego, CA 92121
United States
Phone
Website
Email Address
Not Recorded
Overview
The talented team at Eclipse Bio represents a wide spectrum of science and computational disciplines, which gives us a unique and integrated perspective on RNA genomics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Chu
Chief Scientific Officer
Karen Chapman
Co-Founder
Alexander Shishkin
Browse more venture capital transactions:
Prev: 3/22/2022: Breedr venture capital transaction
Next: 3/22/2022: Threads Styling venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs